Samsung has recently received FDA clearance for its innovative health technology, which allows the Galaxy Watch3 and Galaxy Watch Active2 to detect and notify users of an irregular heart rhythm. This development marks a significant step forward in the company’s commitment to improving public health through technology.

The Samsung Galaxy Watch3 and Galaxy Watch Active2 are equipped with advanced sensors that can detect changes in heart rate and rhythm. By analyzing these changes, the watches can determine if a user is experiencing atrial fibrillation (AFib), which is a common type of irregular heart rhythm that can increase the risk of stroke and other complications.

This technology is particularly useful for individuals who may not be aware of their AFib, as it can be asymptomatic in some cases. The watches can provide an early warning to users, allowing them to seek medical attention and potentially prevent serious health issues.

To use this feature, users simply need to activate the electrocardiogram (ECG) function on their watch, and then place their finger on the side button. The watch will then record the electrical signals from the heart and provide an analysis of the rhythm within 30 seconds.

In addition to the ECG function, the watches also have a blood pressure monitoring feature, which can help users track their blood pressure and potentially detect hypertension. This feature can be particularly helpful for individuals who have a family history of high blood pressure or are at risk for hypertension.

Overall, Samsung’s FDA clearance for irregular heart rhythm notifications is a significant development in the company’s ongoing efforts to improve public health through technology. With this new feature, users can now monitor their heart health more easily and proactively, potentially preventing serious health issues.